These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27720388)

  • 41. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
    Helmeste DM; Tang SW; Bunney WE; Potkin SG; Jones EG
    Eur J Pharmacol; 1996 Oct; 314(3):R3-5. PubMed ID: 8957266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presynaptic regulation of dopamine transmission in schizophrenia.
    Lyon GJ; Abi-Dargham A; Moore H; Lieberman JA; Javitch JA; Sulzer D
    Schizophr Bull; 2011 Jan; 37(1):108-17. PubMed ID: 19525353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.
    Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP
    JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia.
    Ward RD; Winiger V; Higa KK; Kahn JB; Kandel ER; Balsam PD; Simpson EH
    Behav Neurosci; 2015 Jun; 129(3):292-9. PubMed ID: 25914923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
    Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
    Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
    Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
    Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of dopamine for the pathophysiology of schizophrenia.
    Meisenzahl EM; Schmitt GJ; Scheuerecker J; Möller HJ
    Int Rev Psychiatry; 2007 Aug; 19(4):337-45. PubMed ID: 17671867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathway-Specific Dopamine Abnormalities in Schizophrenia.
    Weinstein JJ; Chohan MO; Slifstein M; Kegeles LS; Moore H; Abi-Dargham A
    Biol Psychiatry; 2017 Jan; 81(1):31-42. PubMed ID: 27206569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
    Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
    Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
    Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
    Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits.
    Shilling PD; Kinkead B; Murray T; Melendez G; Nemeroff CB; Feifel D
    Biol Psychiatry; 2006 Dec; 60(11):1278-81. PubMed ID: 16814260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.